User-centred clinical decision support to implement emergency departmentinitiated buprenorphine for opioid use disorder: protocol for the pragmatic group randomised EMBED trial

被引:26
作者
Melnick, Edward R. [1 ]
Jeffery, Molly Moore [2 ]
Dziura, James D. [1 ]
Mao, Jodi A. [3 ]
Hess, Erik P. [4 ]
Platts-Mills, Timothy F. [5 ]
Solad, Yauheni [6 ]
Paek, Hyung [6 ]
Martel, Shara [1 ]
Patel, Mehul D. [7 ]
Bankowski, Laura [1 ]
Lu, Charles [8 ]
Brandt, Cynthia [8 ]
D'Onofrio, Gail [1 ]
机构
[1] Yale Univ, Sch Med, Dept Emergency Med, New Haven, CT 06520 USA
[2] Mayo Clin, Dept Emergency Med, Rochester, MN USA
[3] Eastern Virginia Med Sch, Emergency Med, Norfolk, VA 23501 USA
[4] Univ Alabama Birmingham, Sch Med, Dept Emergency Med, Birmingham, AL USA
[5] Univ N Carolina, Sch Med, Dept Emergency Med, Chapel Hill, NC 27515 USA
[6] Yale New Haven Hlth, Informat Technol Serv, New Haven, CT USA
[7] Univ N Carolina, Sch Med, Dept Emergency Med, Chapel Hill, NC 27515 USA
[8] Yale Univ, Sch Med, Yale Ctr Med Informat, New Haven, CT USA
来源
BMJ OPEN | 2019年 / 9卷 / 05期
关键词
UNITED-STATES; OVERDOSE DEATHS; HEALTH-CARE; DESIGN; SYSTEMS; INTERVENTIONS; PERFORMANCE; DEPENDENCE; RISK;
D O I
10.1136/bmjopen-2018-028488
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction The goal of this trial is to determine whether implementation of a user-centred clinical decision support (CDS) system can increase adoption of initiation of buprenorphine (BUP) into the routine emergency care of individuals with opioid use disorder (OUD). Methods A pragmatic cluster randomised trial is planned to be carried out in 20 emergency departments (EDs) across five healthcare systems over 18 months. The intervention consists of a user-centred CDS integrated into ED clinician electronic workflow and available for guidance to: (1) determine whether patients presenting to the ED meet criteria for OUD, (2) assess withdrawal symptoms and (3) ascertain and motivate patient willingness to initiate treatment. The CDS guides the ED clinician to initiate BUP and facilitate follow-up. The primary outcome is the rate of BUP initiated in the ED. Secondary outcomes are: (1) rates of receiving a referral, (2) fidelity with the CDS and (3) rates of clinicians providing any ED-initiated BUP, referral for ongoing treatment and receiving Drug Addiction Act of 2000 training. Primary and secondary outcomes will be analysed using generalised linear mixed models, with fixed effects for intervention status (CDS vs usual care), prespecified site and patient characteristics, and random effects for study site. Ethics and dissemination The protocol has been approved by the Western Institutional Review Board. No identifiable private information will be collected from patients. A waiver of informed consent was obtained for the collection of data for clinician prescribing and other activities. As a minimal risk implementation study of established best practices, an Independent Study Monitor will be utilised in place of a Data Safety Monitoring Board. Results will be reported in ClinicalTrials.gov and published in open-access, peer-reviewed journals, presented at national meetings and shared with the clinicians at participating sites via a broadcast email notification of publications.
引用
收藏
页数:9
相关论文
共 55 条
  • [1] [Anonymous], RES METH RES
  • [2] [Anonymous], 2013, DIAGNOSTIC STAT MANU, VFifth, P1000
  • [3] [Anonymous], BUPRENORPHINE WAIVER
  • [4] [Anonymous], 2011 NAT EST DRUG RE
  • [5] [Anonymous], SPECIAL CIRCUMSTANCE
  • [6] [Anonymous], 2018, ALC UN
  • [7] [Anonymous], THIS E R TREATS OPIO
  • [8] [Anonymous], 2017, BIORXIV
  • [9] [Anonymous], ANN INTERN MED
  • [10] Ash Joan S, 2007, AMIA Annu Symp Proc, P26